Data Disclaimer: The Nasdaq Indices and the Major Indices are delayed at least 1 minute. 投资者可以进行盘前(美国东部时间上午 4:00 - 9:30) 和盘后(美国东部时间下午 4:00 - 8:00) 交易。做市商和 ECN 严格自愿参与,因此,这些时段的流动性和价格会比较低。在这种环境下,股票价格也可能波动更快。
RT Quote | Last NASDAQ LS, VOL From CTA | USD After Hours: Last | 7:50 AM EDT 23.20+0.02 (+0.09%) Volume 159,796 Close 23.18-0.43 (-1.82%) Volume 32,629,766 52 week range 20.92 - 31.54Latest On Pfizer Inc ALL CNBCINVESTING CLUBPRO ...
Market Cap $12B Current Price $74.53 NASDAQ: EXEL Exelixis Market Cap $10B Current Price $36.86 NYSE: BMY Bristol Myers Squibb Market Cap $97B Current Price $47.57 Premium Investing Services Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more ...
Yeah. Thanks very much, and thanks for all the updates. So my question is just going back to RFK Jr. So assuming he is confirmed as HHS Secretary, and given his history of suing manufacturers and his commentary on lawsuits in the hearings last week, could you just help us understand his...
With Seeking Alpha Premium, you can easily view each stock's full value grade, which takes into account key metrics such as P/E ratio, Price/Book, Price/Sales and Enterprise Value to EBITDA. See more detailed value information. Is Pfizer Inc. listed on the NASDAQ or NYSE? Pfizer Inc. ...
Qualcomm(NASDAQ:QCOM) pays a smaller yield, at 2.8%. But if we can get this name on a dip, that yield will be closer to 3%, while the company hasaccelerating double-digit revenueandearnings growth. My point? Pfizer stock isn’t a bad company, but it doesn’t have any momentum. Its...
Vanguard Institutional Total Stock Market Index Trust 158.59M 2.80% 435.56K 0.29% Oct 31, 2021 Vanguard 500 Index Fund 156.1M 2.76% 2.63M 0.30% Jan 31, 2025 Vanguard Institutional 500 Index Trust 137.88M 2.44% 6.13M 0.41% Dec 31, 2023 Schwab US Dividend Equity ETF 112.56M 1.99% 187.12K ...
PFE's dividend yield, history, payout ratio & much more! Dividend.com: The #1 Source For Dividend Investing.
Since the beginning of the coronavirus crisis, Pfizer has partnered with NASDAQ-listed biotech firm BioNTech to develop a Covid-19 vaccine using novel mRNA technology. At the time of writing, the Pfizer-BioNTech partnership was among the front-runners in the race to develop the vaccine, with ...
The Motley Fool has positions in and recommends Pfizer. The Motley Fool has adisclosure policy. The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc. Tags